Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic ShockFrank Bloos, Onnen Moerer, A. Weyland et al.|JAMA Internal Medicine|2016Cited by 259
Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trialStefan Hagel, Hicham Chkirni, Friedhelm Bach et al.|Intensive Care Medicine|2022Cited by 171
The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trialPatrick Meybohm, Gunnar Elke, Frank Bloos et al.|Critical Care|2018Cited by 119
Efficacy and Safety of Vilobelimab (IFX-1), a Novel Monoclonal Anti-C5a Antibody, in Patients With Early Severe Sepsis or Septic Shock—A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase IIa Trial (SCIENS Study)Michael Bauer, A. Weyland, Gernot Marx et al.|Critical Care Explorations|2021Cited by 36
Studienprotokoll der VISEP-StudieKonrad Reinhart, Frank M. Brunkhorst, Christoph Engel et al.|Der Anaesthesist|2008Cited by 17